AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 131.09 Increased By ▲ 1.56 (1.2%)
BOP 6.95 Increased By ▲ 0.27 (4.04%)
CNERGY 4.61 Decreased By ▼ -0.02 (-0.43%)
DCL 8.91 Decreased By ▼ -0.03 (-0.34%)
DFML 42.95 Increased By ▲ 1.26 (3.02%)
DGKC 83.85 Increased By ▲ 0.08 (0.1%)
FCCL 32.90 Increased By ▲ 0.13 (0.4%)
FFBL 78.00 Increased By ▲ 2.53 (3.35%)
FFL 12.17 Increased By ▲ 0.70 (6.1%)
HUBC 110.35 Decreased By ▼ -0.20 (-0.18%)
HUMNL 14.42 Decreased By ▼ -0.14 (-0.96%)
KEL 5.65 Increased By ▲ 0.26 (4.82%)
KOSM 8.48 Increased By ▲ 0.08 (0.95%)
MLCF 39.40 Decreased By ▼ -0.39 (-0.98%)
NBP 64.25 Increased By ▲ 3.96 (6.57%)
OGDC 201.00 Increased By ▲ 1.34 (0.67%)
PAEL 26.45 Decreased By ▼ -0.20 (-0.75%)
PIBTL 7.77 Increased By ▲ 0.11 (1.44%)
PPL 160.52 Increased By ▲ 2.60 (1.65%)
PRL 26.60 Decreased By ▼ -0.13 (-0.49%)
PTC 18.59 Increased By ▲ 0.13 (0.7%)
SEARL 82.90 Increased By ▲ 0.46 (0.56%)
TELE 8.20 Decreased By ▼ -0.11 (-1.32%)
TOMCL 34.37 Decreased By ▼ -0.14 (-0.41%)
TPLP 9.00 Decreased By ▼ -0.06 (-0.66%)
TREET 16.95 Decreased By ▼ -0.52 (-2.98%)
TRG 60.50 Decreased By ▼ -0.82 (-1.34%)
UNITY 27.81 Increased By ▲ 0.38 (1.39%)
WTL 1.41 Increased By ▲ 0.03 (2.17%)
BR100 10,654 Increased By 247.8 (2.38%)
BR30 31,970 Increased By 256.8 (0.81%)
KSE100 99,544 Increased By 2215.8 (2.28%)
KSE30 31,049 Increased By 856.2 (2.84%)

KARACHI: Roche Diagnostics Pakistan has introduced an innovative product CoaguChek INRange for the patients on warfarin therapy, enabling them to frequently check their International normalized ratio (INR) values conveniently and easily share the results with their consultant via their phone or any other computing device for quick and efficient therapy management.

CoaguChek INRange in partnership with Dawaai.pk will enable users to easily get their result in just one minute by a single drop of blood. This solution will save patients, especially the bed ridden and elderly ones from the hassle of going to the laboratory for testing over and over again followed by visits to their consultants.

According to research conducted by Australian Point of Care Practitioners and Integrated Cardiovascular Clinical Network, Country Health South Australia, published in US National Library of Medicine, National Institutes Health USA, regular monitoring of the anticoagulant effect is required and evidence suggests that patients who self-monitor using point-of-care testing have better outcomes than other patients. With this solution, patients can easily perform the test at their convenience anywhere. This solution is available nationwide at dawaai.pk where professional pharmacists and consultants are available to guide and educate the patients.

Copyright Business Recorder, 2021

Comments

Comments are closed.